clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Disruption of Asxl1 Gene Improves Tumor Control in Immunotherapy
Coronavirus
Long COVID Linked to Persistent Infection
Informatics
AI-Powered Chatbots Unreliable for Patient Drug Information
News & Features
New Therapeutic Strategy Offers Hope for Treating Aggressive Triple-Negative Breast Cancer
Coronavirus
COVID-19 Raises Risk of Heart Attack, Stroke, and Death up to…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Sequencing Rates Unacceptably Low in Metastatic Prostate and Urothelial Cancers
Urothelial carcinoma
News & Features
Sequencing Rates Unacceptably Low in Metastatic Prostate and Urothelial Cancers
Laura Cowen
July 24, 2024
0
News & Features
IDEAYA’s MAT2A Inhibitor Scores in Phase II for Urothelial and NSCLC
July 11, 2024
0
News & Features
First ADC/Immuno-Oncology Combination Approved for Urothelial Cancer
April 4, 2023
0
News & Features
Transcription Factor Specialist Flare Raises $123M and Heads to Clinic
March 22, 2023
0
News & Features
Immunotherapy Reduces Bladder Cancer Recurrence
Alice McCarthy
May 18, 2022
0
News & Features
New Anti-PD-L1 Study Findings Support Immunotherapy for Bladder Cancer
November 13, 2019
0
News & Features
Urothelial Cancer Gets Aid from Precision Medicine
April 5, 2016
0
Related Content
New Research Sheds Light on How Alveolar Macrophages Suppress Metastatic Growth
Blood Test Predicts Outcomes in Newly Diagnosed Metastatic Prostate Cancer
New Research Identifies DAPK3 as a Regulator of Metastasis in Triple-Negative Breast Cancer
Genetic Variants Linked to Maternal and Newborn Disease in China Uncovered
Inside Precision Medicine
![Drug demonstrates significant activity in patients with platinum-refractory urothelial cancer. [National Cancer Institute]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/602.jpeg "Urothelial Cancer Gets Aid from Precision Medicine")
